Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Infection Control 2019

About Conference

With the grand success from the previous relevant annual International conferences, ConferenceSeries Ltd is organizing “Infectious Diseases: Control and Prevention” (Infection Control 2019) scheduled during May 17-18, 2019 in Philadelphia, USA. Infection Control 2019 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.

Conference Series organizes a conference series  of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2019 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions.

Infection control is required to prevent the transmission of communicable diseases in all health care settings. Infection control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. the risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals
  • Infectious Diseases Specialists
  • Infection Prevention and Infection Control Specialists

Why to attend?

With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

For Scientific Sessions please go through the link:

For Abstract Submission please go through the link:


Market Analysis

Importance and Scope

The market is projected to reach USD 33.78 billion by 2021 and is growing at a CAGR of 8.3% during the forecast period which is from 2016 to 2021. Hospital acquired infections are also called as nosocomial infections and that are acquired in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission or up to 3 days after discharge or up to 30 days after an operation or in a healthcare facility, when the patient was admitted for reasons other than infection.

The global hospital acquired infection control market is categorized which is on the basis of Pathogen Types (Viral, Bacterial, and Fungal), Treatment (Air, Water, Physical Surfaces, Skin Disinfectants, and Sterilization), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Hospital Acquired Pneumonia, Gastrointestinal Infections, and Tuberculosis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Conferenceseries welcomes all the specialists and super specialists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Infection Control-2019. It also catalyses for information exchange and networking between researchers and business entrepreneurs of diverse backgrounds for the advancement of Technology and Research in the field of Infection Control. As this will be the best amalgamation of academia and research involving every aspect of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why Philadelphia?
   Philadelphia is the largest city in the Commonwealth of Pennsylvania and the 6th most crowded city in the United States, with an expected populace of 1,567,872 and more than 6 million in the seventh-biggest metropolitan measurable zone, starting at 2016.Philadelphia is the financial and social stay of the Delaware Valley—a district situated in the Northeastern United States at the intersection of the Delaware and Schuylkill Rivers with 7.2 million individuals dwelling in the eighth-biggest joined factual region in the United States.

The Philadelphia territory's numerous colleges and schools make it a best report goal, as the city has advanced into an instructive and monetary center point. With a GDP of $388 billion, Philadelphia positions ninth among world urban communities and fourth in the country. Philadelphia is the focal point of financial action in Pennsylvania and is home to five Fortune 1000 organizations. The Philadelphia horizon is developing, with a market of just about 81,900 business properties in 2016 including a few broadly unmistakable high rises. The city is known for its specialties, culture, and rich history, drawing in more than 41 million local sightseers alone in 2015. Philadelphia has more open air figures and paintings than some other American city. Fairmount Park, when joined with the nearby Wissahickon Valley Park in a similar watershed, is one of the biggest coterminous urban stop ranges in the United States. The 67 National Historic Landmarks in the city helped represent the $10 billion produced by tourism. Philadelphia is the origination of the United States Marine Corps and is likewise the home of numerous U.S. firsts, including the primary library (1731) first healing facility (1751) and medicinal school (1765), first Capital (1777), first stock trade (1790), first zoo (1874) and first business college (1881).Philadelphia is the main World Heritage City in the United States.

Conference Highlights

·         Infection Treatment and Control

·         Emerging Infectious Diseases

·         Infection Novel Therapies

·         Treatment & Diagnosis

·         Healthcare-Associated Infection (HAIs)

·         HIV/AIDS from STDs & STIs

·         Infection by Zoonoses

·         Disinfection/Sterilization

·         Infections from Plants

·         Multidrug-Resistant Microorganisms

·         Infections During Pregnancy

·         Pediatric Infectious Diseases

·         Practices and Awareness

·         Multi Pathogen Infections

·         Practical Guidelines

·         Infection Control Business

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Statistics of Researchers, Academicians and Industrial

·         International Federation of Infection Control (IFIC)

·         Association for Professionals in Infection Control and Epidemiology(APIC)

·         Infection Prevention Society (IPS)

·         American Journal of Infection Control(AJIC) 

·         Centers for Disease Control and Prevention(CDC)

·         Infectious Disease Society of America (IDSA)

·         Infectious Diseases Research Network (IDRN)

·         Australasian College for Infection Prevention and Control (ACIPC)

·         European Society for Clinical Microbiology and Infectious Diseases (ESCMID)

·         British Infection Association(BNA)

·         The Hospital Infection Society (HIS)

·         Infection Prevention Society (IPS)

·         World Health Organization (WHO) 

·         American Nurses Association(ANA)

·         Nigerian Infection Control Association (NICA) 

·         Infection Control Society of Southern Africa(ICSSA)

·         Washington State Hospital Association (WSHA)

Top Universities Worldwide

·         The University of British Columbia, Canada

·         American Sentinel University, USA

·         University of Toronto, Canada

·         University of South Florida,USA

·         Drexel University,USA

·         Griffith University,AUSTRALIA

·         Columbia University,USA

·         King's College London, University of London,UK

·         University of Dundee, Uk

·         University of Oxford,Uk

·         University of Cambridge,UK

·         Western University (Ontario), Canada

·         University of Otago, NEW ZEALAND

·         Imperial College London,UK

·         UCL (University College London),UK

·         Toi-Ohomai Institute of Technology, NEW ZEALAND

·         The University of Sydney, AUSTRALIA

·         Keele University, UK

Infection Control Therapeutic Market

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Infection Control Market worth 17.78 Billion USD by 2021

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America. America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. 

The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories.

The report "Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa in the coming years


The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.

However, the lack of awareness regarding hospital acquired infection and increased usage of outpatient treatment are hampering the growth of this market.


To Collaborate Scientific Professionals around the World

Conference Date May 17-18, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Infectious Diseases and Therapy

Air and Water Borne Diseases

Journal of Immunological Techniques in Infectious Diseases

Journal of Bacteriology and Parasitology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by